Aristogene Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 4.19 M
- Company Age 19 Year, 30 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.70 M
- Satisfied Charges ₹ 6.00 M
- Revenue Growth -3.60%
- Profit Growth -37.36%
- Ebitda -33.54%
- Net Worth 16.69%
- Total Assets 4.40%
About Aristogene Biosciences
Aristogene Biosciences Private Limited (ABPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 January 2006 and has a history of 19 years. Its registered office is in Bangalore, Karnataka.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.19 M.
The company currently has active open charges totaling ₹1.70 M. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Subhashini Rangamani, Vasudha Balasundaram, and Sudha Lingappa serve as directors at the Company.
Company Details
- Location Bangalore, Karnataka
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231KA2006PTC038261
-
Company No.
038261
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jan 2006
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Aristogene Biosciences Private Limited offer?
Aristogene Biosciences Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Hematology Analyzers, Electrophoresis Equipment.
Who are the key members and board of directors at Aristogene Biosciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhashini Rangamani
|
Director | 17-Jan-2006 | Current |
|
Vasudha Balasundaram
|
Director | 17-Jan-2006 | Current |
|
Sudha Lingappa
|
Director | 17-Jan-2006 | Current |
Financial Performance of Aristogene Biosciences.
Aristogene Biosciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.6% decrease. The company also saw a substantial fall in profitability, with a 37.36% decrease in profit. The company's net worth Soared by an impressive increase of 16.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aristogene Biosciences?
In 2023, Aristogene Biosciences had a promoter holding of 96.66% and a public holding of 3.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.17 Cr
₹0.60 Cr
Charges Breakdown by Lending Institutions
- Biotechnology Industry Research Assistance Council : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jan 2015 | Biotechnology Industry Research Assistance Council | ₹1.70 M | Open |
| 23 Jun 2014 | Karnataka State Financial Corporation | ₹6.00 M | Satisfied |
How Many Employees Work at Aristogene Biosciences?
Aristogene Biosciences has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aristogene Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aristogene Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
